Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,070 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The clinical spectrum of HbSC sickle cell disease-not a benign condition.
Nelson M, Noisette L, Pugh N, Gordeuk V, Hsu LL, Wun T, Shah N, Glassberg J, Kutlar A, Hankins JS, King AA, Brambilla D, Kanter J. Nelson M, et al. Among authors: shah n. Br J Haematol. 2024 Aug;205(2):653-663. doi: 10.1111/bjh.19523. Epub 2024 Jun 19. Br J Haematol. 2024. PMID: 38898714
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.
Vichinsky E, Hoppe CC, Ataga KI, Ware RE, Nduba V, El-Beshlawy A, Hassab H, Achebe MM, Alkindi S, Brown RC, Diuguid DL, Telfer P, Tsitsikas DA, Elghandour A, Gordeuk VR, Kanter J, Abboud MR, Lehrer-Graiwer J, Tonda M, Intondi A, Tong B, Howard J; HOPE Trial Investigators. Vichinsky E, et al. N Engl J Med. 2019 Aug 8;381(6):509-519. doi: 10.1056/NEJMoa1903212. Epub 2019 Jun 14. N Engl J Med. 2019. PMID: 31199090 Clinical Trial.
Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab study.
Liles DK, Shah NR, Scullin B, Gordeuk VR, Smith WR, Kanter J, Achebe MM, Boccia R, Crary SE, Kraft WK, Archer N, Cataldo V, Hardesty BM, Idowu M, Desai PC, Ikeda A, Puthenveetil G, Hassell KL, Sarnaik S, Kutlar A. Liles DK, et al. Among authors: shah nr. Br J Haematol. 2021 Nov;195(4):e150-e153. doi: 10.1111/bjh.17739. Epub 2021 Oct 5. Br J Haematol. 2021. PMID: 34611900 No abstract available.
Pregnancy outcomes with hydroxyurea use in women with sickle cell disease.
Kroner BL, Hankins JS, Pugh N, Kutlar A, King AA, Shah NR, Kanter J, Glassberg J, Treadwell M, Gordeuk VR; Sickle Cell Disease Implementation Consortium. Kroner BL, et al. Among authors: shah nr. Am J Hematol. 2022 May;97(5):603-612. doi: 10.1002/ajh.26495. Epub 2022 Feb 17. Am J Hematol. 2022. PMID: 35142007 Free PMC article.
Impact of the COVID-19 Pandemic on the Implementation of Mobile Health to Improve the Uptake of Hydroxyurea in Patients With Sickle Cell Disease: Mixed Methods Study.
Badawy SM, DiMartino L, Brambilla D, Klesges L, Baumann A, Burns E, DeMartino T, Jacobs S, Khan H, Nwosu C, Shah N, Hankins JS; Sickle Cell Disease Implementation Consortium. Badawy SM, et al. Among authors: shah n. JMIR Form Res. 2022 Oct 14;6(10):e41415. doi: 10.2196/41415. JMIR Form Res. 2022. PMID: 36240004 Free PMC article.
Characterising the prevalence of overweight and obese status among adults with sickle cell disease.
Ibemere SO, Oyedeji CI, Preiss L, Van Althuis LE, Hankins JS, Azul M, Burns EN, Glassberg J, Hagar W, Hussain F, King A, Melvin C, Myers J, Snyder A, Shah N, Tanabe P; Sickle Cell Disease Implementation Consortium. Ibemere SO, et al. Among authors: shah n. Br J Haematol. 2023 Mar;200(5):633-642. doi: 10.1111/bjh.18548. Epub 2022 Nov 16. Br J Haematol. 2023. PMID: 36382420 Free PMC article.
Evaluating the implementation of a multi-level mHealth study to improve hydroxyurea utilization in sickle cell disease.
Hankins JS, Potter MB, Fernandez ME, Melvin C, DiMartino L, Jacobs SR, Bosworth HB, King AA, Simon J, Glassberg JA, Kutlar A, Gordeuk VR, Shah N, Baumann AA, Klesges LM; Sickle Cell Disease Implementation Consortium. Hankins JS, et al. Among authors: shah n. Front Health Serv. 2023 Jan 20;2:1024541. doi: 10.3389/frhs.2022.1024541. eCollection 2022. Front Health Serv. 2023. PMID: 36925803 Free PMC article.
Burden of Aging: Health Outcomes Among Adolescents and Young Adults With Sickle Cell Disease.
Howell KE, Pugh N, Longoria J, Shah N, Kutlar A, Gordeuk VR, King AA, Glassberg J, Kayle M, Melvin C, Treadwell M, Hankins JS, Porter JS. Howell KE, et al. Among authors: shah n. Hemasphere. 2023 Jul 13;7(8):e930. doi: 10.1097/HS9.0000000000000930. eCollection 2023 Aug. Hemasphere. 2023. PMID: 37456969 Free PMC article. No abstract available.
Biopsychosocial Factors Associated With Pain and Pain-Related Outcomes in Adults and Children With Sickle Cell Disease: A Multivariable Analysis of the GRNDaD Multicenter Registry.
Kenney MO, Wilson S, Shah N, Bortsov A, Smith WR, Little J, Lanzkron S, Kanter J, Padrino S, Owusu-Ansah A, Cohen A, Desai P, Manwani D, Rehman SSU, Hagar W, Keefe F. Kenney MO, et al. Among authors: shah n. J Pain. 2024 Jan;25(1):153-164. doi: 10.1016/j.jpain.2023.07.029. Epub 2023 Aug 5. J Pain. 2024. PMID: 37544393 Free PMC article.
Mental health, pain and likelihood of opioid misuse among adults with sickle cell disease.
Jonassaint CR, Parchuri E, O'Brien JA, Lalama CM, Lin J, Badawy SM, Hamm ME, Stinson J, Lalloo C, Carroll CP, Saraf SL, Gordeuk VR, Cronin R, Shah N, Lanzkron SM, Liles D, Trimnell C, Bailey L, Lawrence RH, Abebe KZ. Jonassaint CR, et al. Among authors: shah n. Br J Haematol. 2024 Mar;204(3):1029-1038. doi: 10.1111/bjh.19243. Epub 2024 Jan 3. Br J Haematol. 2024. PMID: 38171495
9,070 results